Symbols
Symbols
Aime
Products
News
Markets
Watchlist
Brokers
US Stocks
/
ACRS
/
revenue
A
ACRS
EPS
Revenue & Expenses
Why did Aclaris Therapeutics' operating expenses drop sharply in Q4 2024?
Ask Aime more questions
